Evoke Wealth’s Ingevity NGVT Stock Holding History

Evoke Wealth’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-293	Closed	-$25.6K	–	1282
2019 Q4	$25.6K	Buy	293 +23	+9%	+$2.01K	﹤0.01%	539
2019 Q3	$22.9K	Buy	+270	New	+$24.1K	﹤0.01%	618

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

Evoke Wealth's NGVT Position: Q1 2020 in Review

Evoke Wealth sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 293 shares — an estimated $25.6K sold.

Evoke Wealth first reported a position in NGVT in Q3 2019 and held it in 2 quarters. The position peaked at $25.6K in Q4 2019. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

Evoke Wealth reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
Evoke Wealth sold 293 Ingevity shares in Q1 2020, an estimated $25.6K.
Evoke Wealth first reported a position in Ingevity in Q3 2019 and held it in 2 quarters.
Evoke Wealth's Ingevity position peaked at $25.6K in Q4 2019.
272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.